• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对轮状病毒感染的DNA疫苗。

DNA vaccines against rotavirus infections.

作者信息

Herrmann J E, Chen S C, Fynan E F, Santoro J C, Greenberg H B, Robinson H L

机构信息

Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, USA.

出版信息

Arch Virol Suppl. 1996;12:207-15. doi: 10.1007/978-3-7091-6553-9_22.

DOI:10.1007/978-3-7091-6553-9_22
PMID:9015117
Abstract

Plasmid DNA vaccines encoding for murine rotaviral proteins VP4, VP6, and VP7 were tested in adult BALB/c mice for their ability to induce immune responses and provide protection against rotavirus challenge. Serum antibodies were measured by virus neutralization and by ELISA. Cellular immunity was assessed by measuring cytotoxic T cell (CTL) responses. The vaccines were administered by inoculation into cells of the epidermis with an Accell gene gun (Auragen, Inc., Middleton, WI, USA). Each of the three vaccines elicited rotavirus-specific serum antibodies as measured by ELISA. Virus neutralizing antibodies were detected in mice receiving DNA vaccines encoding for VP4 and VP7, but not in those which received the plasmid encoding for VP6. Vaccines encoding for VP4, VP6, or VP7 generated virus-specific CTL responses in recipient mice. Efficacy of the vaccines was determined by challenge with homotypic rotaviruses. Each of the three vaccines was effective in protecting mice against infection after rotavirus (100 ID50) challenge. Significant reductions (p < 0.0002, analysis of variance) in viral excretion measured over a 9 day period were seen in mice receiving the DNA vaccines compared with mice that received control plasmids.

摘要

对编码鼠轮状病毒蛋白VP4、VP6和VP7的质粒DNA疫苗在成年BALB/c小鼠中进行了测试,以评估其诱导免疫反应及提供针对轮状病毒攻击的保护能力。通过病毒中和试验和酶联免疫吸附测定法检测血清抗体。通过测量细胞毒性T细胞(CTL)反应评估细胞免疫。使用Accell基因枪(美国威斯康星州米德尔顿市的Auragen公司)将疫苗接种到表皮细胞中。通过酶联免疫吸附测定法测定,三种疫苗均能诱导出轮状病毒特异性血清抗体。在接受编码VP4和VP7的DNA疫苗的小鼠中检测到病毒中和抗体,但在接受编码VP6的质粒的小鼠中未检测到。编码VP4、VP6或VP7的疫苗在受体小鼠中产生了病毒特异性CTL反应。通过用同型轮状病毒攻击来确定疫苗的效力。三种疫苗均能有效保护小鼠免受轮状病毒(100个半数感染剂量)攻击后的感染。与接受对照质粒的小鼠相比,接受DNA疫苗的小鼠在9天内测量的病毒排泄量显著降低(方差分析,p < 0.0002)。

相似文献

1
DNA vaccines against rotavirus infections.针对轮状病毒感染的DNA疫苗。
Arch Virol Suppl. 1996;12:207-15. doi: 10.1007/978-3-7091-6553-9_22.
2
Protective immunity induced by rotavirus DNA vaccines.轮状病毒DNA疫苗诱导的保护性免疫。
Vaccine. 1997 Jun;15(8):899-902. doi: 10.1016/s0264-410x(96)00272-1.
3
Protection against rotavirus infections by DNA vaccination.
J Infect Dis. 1996 Sep;174 Suppl 1:S93-7. doi: 10.1093/infdis/174.supplement_1.s93.
4
Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.用轮状病毒VP4或VP7进行粒子轰击介导的DNA疫苗接种可诱导高水平的血清轮状病毒IgG,但不能保护小鼠免受攻击。
Virology. 1998 Oct 10;250(1):230-40. doi: 10.1006/viro.1998.9370.
5
Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles.用包裹在微粒中的轮状病毒VP4和VP7 DNA疫苗进行口服免疫所获得的免疫反应和保护作用。
Virology. 1999 Jun 20;259(1):148-53. doi: 10.1006/viro.1999.9751.
6
Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.
Vaccine. 2001 Apr 30;19(23-24):3285-91. doi: 10.1016/s0264-410x(00)00543-0.
7
Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.用轮状病毒VP6进行粒子轰击介导的DNA疫苗接种可诱导高水平的血清轮状病毒IgG,但不能保护小鼠免受攻击。
Virology. 1997 May 26;232(1):129-38. doi: 10.1006/viro.1997.8552.
8
Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.一种非中和性、轮状病毒VP6特异性IgA单克隆抗体对轮状病毒复制的抑制作用
J Clin Invest. 2002 May;109(9):1203-13. doi: 10.1172/JCI14397.
9
Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines.接种特定口服轮状病毒活疫苗的婴儿对轮状病毒非结构蛋白4以及病毒蛋白(VP)4、VP6和VP7的同型和异型血清同种型特异性抗体反应。
J Infect Dis. 2004 May 15;189(10):1833-45. doi: 10.1086/383416. Epub 2004 Apr 29.
10
Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential.重组轮状病毒蛋白组装成病毒样颗粒及疫苗潜力评估。
Vaccine. 1993;11(2):273-81. doi: 10.1016/0264-410x(93)90029-w.

引用本文的文献

1
Rotavirus VP6: involvement in immunogenicity, adjuvant activity, and use as a vector for heterologous peptides, drug delivery, and production of nano-biomaterials.轮状病毒 VP6:在免疫原性、佐剂活性中的作用,以及作为异源肽、药物传递和纳米生物材料生产的载体的用途。
Arch Virol. 2022 Apr;167(4):1013-1023. doi: 10.1007/s00705-022-05407-9. Epub 2022 Mar 15.
2
The performance of licensed rotavirus vaccines and the development of a new generation of rotavirus vaccines: a review.已获许可的轮状病毒疫苗的性能及新一代轮状病毒疫苗的研发:综述
Hum Vaccin Immunother. 2021 Mar 4;17(3):880-896. doi: 10.1080/21645515.2020.1801071. Epub 2020 Sep 23.
3
DNA immunization.
DNA免疫
Curr Protoc Microbiol. 2013 Nov 5;31:18.3.1-18.3.24. doi: 10.1002/9780471729259.mc1803s31.
4
Development of a Bacillus subtilis-based rotavirus vaccine.基于枯草芽孢杆菌的轮状病毒疫苗的研发。
Clin Vaccine Immunol. 2010 Nov;17(11):1647-55. doi: 10.1128/CVI.00135-10. Epub 2010 Sep 1.
5
Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.用嵌合VP4或VP6蛋白经鼻内免疫刺激小鼠产生的针对轮状病毒感染的非抗体依赖性保护作用。
J Virol. 1999 Sep;73(9):7574-81. doi: 10.1128/JVI.73.9.7574-7581.1999.
6
Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles.用包裹在微粒中的轮状病毒DNA疫苗进行口服免疫诱导的保护性免疫。
J Virol. 1998 Jul;72(7):5757-61. doi: 10.1128/JVI.72.7.5757-5761.1998.
7
Genetic vaccines: strategies for optimization.基因疫苗:优化策略
Pharm Res. 1998 May;15(5):661-70. doi: 10.1023/a:1011950415325.